These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9354968

  • 1. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S, Kamachi K, Konda T, Komuro K, Uchida T.
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H, Sato Y.
    Dev Biol Stand; 1985 Feb; 61():461-7. PubMed ID: 2872127
    [Abstract] [Full Text] [Related]

  • 4. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG.
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [Abstract] [Full Text] [Related]

  • 5. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A, van Straaten-van de Kappelle I, Akkermans A, Hendriksen C, van de Donk H.
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [Abstract] [Full Text] [Related]

  • 6. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.
    Byrne P, McGuirk P, Todryk S, Mills KH.
    Eur J Immunol; 2004 Sep; 34(9):2579-88. PubMed ID: 15307190
    [Abstract] [Full Text] [Related]

  • 7. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
    van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.
    Vaccine; 2000 Dec 08; 19(9-10):1118-28. PubMed ID: 11137247
    [Abstract] [Full Text] [Related]

  • 8. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A, van Straaten-van de Kappelle I, Hendriksen C, van de Donk H.
    Dev Biol Stand; 1996 Dec 08; 86():271-81. PubMed ID: 8785956
    [Abstract] [Full Text] [Related]

  • 9. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
    Canthaboo C, Xing D, Corbel M.
    Dev Biol Stand; 1999 Dec 08; 101():95-103. PubMed ID: 10566781
    [Abstract] [Full Text] [Related]

  • 10. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP, Pohl-Koppe A.
    Eur J Med Res; 1998 Nov 17; 3(11):523-6. PubMed ID: 9810032
    [Abstract] [Full Text] [Related]

  • 11. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C, Xing D, Douglas A, Corbel M.
    Biologicals; 2000 Dec 17; 28(4):241-6. PubMed ID: 11237360
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
    Zawadka M, Polak M, Rabczenko D, Mosiej E, Augustynowicz E, Lutyńska A.
    Vaccine; 2011 Jul 26; 29(33):5488-94. PubMed ID: 21641954
    [Abstract] [Full Text] [Related]

  • 13. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.
    Mahon BP, Brady MT, Mills KH.
    J Infect Dis; 2000 Jun 26; 181(6):2087-91. PubMed ID: 10837200
    [Abstract] [Full Text] [Related]

  • 14. Studies on the immunizing capacity of orally administered particulate antigens. I. The efficiency of killed Bordetella pertussis cells.
    Hof H, Finger H, Körner L, Milcke L.
    Zentralbl Bakteriol Orig A; 1975 Jun 26; 230(2):210-22. PubMed ID: 167535
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A, Pereira AS, Moreira-Filho CA, Bando SY, Tambourgi DV.
    Vaccine; 2005 Jul 29; 23(34):4353-8. PubMed ID: 16005744
    [Abstract] [Full Text] [Related]

  • 16. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R, Moreno G, Bottero D, Gaillard ME, Fingermann M, Graieb A, Rumbo M, Hozbor D.
    Vaccine; 2008 Aug 26; 26(36):4639-46. PubMed ID: 18640169
    [Abstract] [Full Text] [Related]

  • 17. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.
    McGuirk P, Mills KH.
    Eur J Immunol; 2000 Feb 26; 30(2):415-22. PubMed ID: 10671196
    [Abstract] [Full Text] [Related]

  • 18. Treatment of mice with IL-12 DNA constructs leads to augmented NK activity in lungs but low IFN-gamma release -- implications for Bordetella pertussis infections following aerosol challenge.
    Carter CR, Dagg BM, Whitmore KM, Keeble JR, Asokanathan C, Rodgers A, Watanabe M, Xing D, Walker KB.
    Cytokine; 2005 May 07; 30(3):100-8. PubMed ID: 15826816
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC, Risoléo L, Lopes AP, Ferreira VR, Quintilio W, Lépine F, Silva WD, Raw I.
    Vaccine; 2007 Jan 08; 25(4):621-9. PubMed ID: 17011680
    [Abstract] [Full Text] [Related]

  • 20. Protective immunity against Bordetella pertussis by a recombinant DNA vaccine and the effect of coinjection with a granulocyte-macrophage colony stimulating factor gene.
    Li Q, Zhu Y, Chu J, Wang Y, Xu Y, Hou Q, Zhang S, Guo X.
    Microbiol Immunol; 2006 Jan 08; 50(12):929-36. PubMed ID: 17179660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.